Key result
A survey of 41 European centres showed adoption of ESC guidelines for AF and ACS, but highlighted uncertainty regarding optimal antithrombotic therapy composition and duration.
Cross-Sectional (n=41)
Yes
This European survey highlights that while ESC guidelines for AF and ACS are generally adopted, significant uncertainty remains regarding optimal combination antithrombotic therapy.
Answers are grounded in this paper and cite their sources.
Highlights current European practices amid limited evidence for AF with ACS; leaves open need for dedicated trials.
Management of patients with non-valvular atrial fibrillation (AF) presenting with an acute coronary syndrome (ACS) may be particularly challenging. Given the lack of sound evidence-based recommendations for the management of such patients, the aim of this European Heart Rhythm Association survey was to provide an insight into current practice in Europe regarding management of these patients. Overall, 41 centres submitted a valid response. The majority of respondents were university hospitals (85%). The survey has shown that the principal aspects of the European Society of Cardiology guidelines on the management of AF, and those on ACS, have been adopted. The survey highlights two important areas of uncertainty regarding the optimal composition and duration of antithrombotic therapy with multiple drugs and the optimal regimen(s) of novel oral anticoagulants in patients with AF and ACS.
No takes yet. Share an insight, caveat, or question.
Potpara et al. (2014) conducted a cross-sectional in Non-valvular atrial fibrillation with acute coronary syndrome (n=41). Management practices was evaluated on Current practice and guideline adoption. A survey of 41 European centres showed adoption of ESC guidelines for AF and ACS, but highlighted uncertainty regarding optimal antithrombotic therapy composition and duration.
Synapse has enriched 10 related papers. Consider them for comparative context: